Literature DB >> 12799454

Triplex formation with 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) having C3'-endo conformation at physiological pH.

Makoto Koizumi1, Koji Morita, Makiko Daigo, Shinya Tsutsumi, Koji Abe, Satoshi Obika, Takeshi Imanishi.   

Abstract

Antigenes, which are substances that inhibit gene expression by binding to double-stranded DNA (dsDNA) in a sequence-specific manner, are currently sought for the treatment of various gene-related diseases. As such antigenes, we developed new nuclease-resistant oligopyrimidine nucleotides that are partially modified with 2'-O,4'-C-ethylene nucleic acids (ENA), which are constrained in the C3'-endo conformation and can form a triplex with dsDNA at physiological pH. It was found that these oligonucleotides formed triplexes similarly to those partially modified with 2'-O,4'-C-methylene nucleic acids (2',4'-BNA or LNA), as determined by UV melting analyses, electromobility shift assays, CD spectral analyses and restriction enzyme inhibition assays. In our studies, oligonucleotides fully modified with ENA have delta torsion angle values that are marginally higher than those of 2',4'-BNA/LNA. ENA oligonucleotides present in 10-fold the amount of dsDNA were found to be favorable in forming triplexes. These results provide useful information for the future design of triplex-forming oligonucleotides fully modified with such nucleic acids constrained in the C3'-endo conformation considering that oligonucleotides fully modified with 2',4'-BNA/LNA do not form triplexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799454      PMCID: PMC162250          DOI: 10.1093/nar/gkg416

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  Antisense oligonucleotides as a tool for gene functionalization and target validation.

Authors:  C F Bennett; L M Cowsert
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  2'-O,4'-C-Methylene bridged nucleic acid (2',4'-BNA): synthesis and triplex-forming properties.

Authors:  S Obika; T Uneda; T Sugimoto; D Nanbu; T Minami; T Doi; T Imanishi
Journal:  Bioorg Med Chem       Date:  2001-04       Impact factor: 3.641

4.  3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.

Authors:  S Obika; M Onoda; K Morita; J Andoh; M Koizumi; T Imanishi
Journal:  Chem Commun (Camb)       Date:  2001-10-07       Impact factor: 6.222

5.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Authors:  L C Bock; L C Griffin; J A Latham; E H Vermaas; J J Toole
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

6.  2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides.

Authors:  R H Griffey; B P Monia; L L Cummins; S Freier; M J Greig; C J Guinosso; E Lesnik; S M Manalili; V Mohan; S Owens; B R Ross; H Sasmor; E Wancewicz; K Weiler; P D Wheeler; P D Cook
Journal:  J Med Chem       Date:  1996-12-20       Impact factor: 7.446

7.  Design of antisense oligonucleotides stabilized by locked nucleic acids.

Authors:  Jens Kurreck; Eliza Wyszko; Clemens Gillen; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

Review 8.  Fomivirsen: clinical pharmacology and potential drug interactions.

Authors:  Richard S Geary; Scott P Henry; Lisa R Grillone
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Triple helix formation by oligopurine-oligopyrimidine DNA fragments. Electrophoretic and thermodynamic behavior.

Authors:  G Manzini; L E Xodo; D Gasparotto; F Quadrifoglio; G A van der Marel; J H van Boom
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

10.  The high-output nitric oxide pathway: role and regulation.

Authors:  Q Xie; C Nathan
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

View more
  9 in total

1.  Solution structure of a dsDNA:LNA triplex.

Authors:  Jesper J Sørensen; Jakob T Nielsen; Michael Petersen
Journal:  Nucleic Acids Res       Date:  2004-11-18       Impact factor: 16.971

2.  Optimized DNA-targeting using triplex forming C5-alkynyl functionalized LNA.

Authors:  Sujay P Sau; Pawan Kumar; Brooke A Anderson; Michael E Østergaard; Lee Deobald; Andrzej Paszczynski; Pawan K Sharma; Patrick J Hrdlicka
Journal:  Chem Commun (Camb)       Date:  2009-10-12       Impact factor: 6.222

3.  Invader LNA: efficient targeting of short double stranded DNA.

Authors:  Sujay P Sau; T Santhosh Kumar; Patrick J Hrdlicka
Journal:  Org Biomol Chem       Date:  2010-03-04       Impact factor: 3.876

Review 4.  DNA triple helices: biological consequences and therapeutic potential.

Authors:  Aklank Jain; Guliang Wang; Karen M Vasquez
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

5.  Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.

Authors:  Keith T Gagnon; Hannah M Pendergraff; Glen F Deleavey; Eric E Swayze; Pierre Potier; John Randolph; Eric B Roesch; Jyoti Chattopadhyaya; Masad J Damha; C Frank Bennett; Christophe Montaillier; Marc Lemaitre; David R Corey
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

6.  Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.

Authors:  Erika Brunet; Maddalena Corgnali; Fabio Cannata; Loïc Perrouault; Carine Giovannangeli
Journal:  Nucleic Acids Res       Date:  2006-09-01       Impact factor: 16.971

7.  Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.

Authors:  Erika Brunet; Maddalena Corgnali; Loïc Perrouault; Victoria Roig; Ulysse Asseline; Mads D Sørensen; B Ravindra Babu; Jesper Wengel; Carine Giovannangeli
Journal:  Nucleic Acids Res       Date:  2005-07-27       Impact factor: 16.971

8.  Next-generation bis-locked nucleic acids with stacking linker and 2'-glycylamino-LNA show enhanced DNA invasion into supercoiled duplexes.

Authors:  Sylvain Geny; Pedro M D Moreno; Tomasz Krzywkowski; Olof Gissberg; Nicolai K Andersen; Abdirisaq J Isse; Amro M El-Madani; Chenguang Lou; Y Vladimir Pabon; Brooke A Anderson; Eman M Zaghloul; Rula Zain; Patrick J Hrdlicka; Per T Jørgensen; Mats Nilsson; Karin E Lundin; Erik B Pedersen; Jesper Wengel; C I Edvard Smith
Journal:  Nucleic Acids Res       Date:  2016-02-08       Impact factor: 16.971

9.  Fluorescent intercalator displacement replacement (FIDR) assay: determination of relative thermodynamic and kinetic parameters in triplex formation--a case study using triplex-forming LNAs.

Authors:  Sujay P Sau; Pawan Kumar; Pawan K Sharma; Patrick J Hrdlicka
Journal:  Nucleic Acids Res       Date:  2012-08-01       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.